Literature DB >> 25466265

The effects of corticosteroids on cytokine production from asthma lung lymphocytes.

Manminder Kaur, Sophie Reynolds, Lucy J Smyth, Karen Simpson, Simon Hall, Dave Singh.   

Abstract

BACKGROUND: Lymphocytes play a central role in the pathophysiology of asthma. Corticosteroids have a limited effect in severe asthma and we hypothesise that lymphocytes play a central role in corticosteroid insensitivity. We investigated the effects of corticosteroids on cytokine production from lung lymphocytes obtained from patients with moderate severe asthma (MSA) compared to mild asthma (MA) and healthy non-smokers (HNS).
METHODS: Bronchoalveolar lavage (BAL) cells obtained by bronchoscopy from patients with MSA and MA (n = 11 and n = 14 respectively) and HNS (n = 7) were stimulated with CD2/3/28 beads to activate the lymphocytes, in the presence or absence of dexamethasone (0.01-1 μM). Supernatants were assayed for IL-2, IFNγ, IL-17, IL-13 and IL-10 production.
RESULTS: Dexamethasone caused variable inhibition of cytokines; 1 μM inhibited IL-10 and IL-17 by 50% or lower, while inhibition > 50% was observed for IL-2, IL-13 and IFNγ. The effect of dexamethasone on IL-13 production was reduced in MSA.
CONCLUSION: These findings suggest that the production of specific lymphocyte derived cytokines is poorly suppressed by corticosteroids in MSA, which may be responsible for persistent airway inflammation in these patients

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25466265     DOI: 10.1016/j.intimp.2014.10.008

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  6 in total

1.  Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids.

Authors:  Michael C Peters; Sheena Kerr; Eleanor M Dunican; Prescott G Woodruff; Merritt L Fajt; Bruce D Levy; Elliot Israel; Brenda R Phillips; David T Mauger; Suzy A Comhair; Serpil C Erzurum; Mats W Johansson; Nizar N Jarjour; Andrea M Coverstone; Mario Castro; Annette T Hastie; Eugene R Bleecker; Sally E Wenzel; John V Fahy
Journal:  J Allergy Clin Immunol       Date:  2018-03-07       Impact factor: 10.793

2.  TH1 signatures are present in the lower airways of children with severe asthma, regardless of allergic status.

Authors:  Julia A Wisniewski; Lyndsey M Muehling; Jacob D Eccles; Brian J Capaldo; Rachana Agrawal; Debbie-Ann Shirley; James T Patrie; Lisa J Workman; Alexander J Schuyler; Monica G Lawrence; W Gerald Teague; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2017-09-20       Impact factor: 10.793

3.  Increased expression of IL1-RL1 is associated with type 2 and type 1 immune pathways in asthma.

Authors:  Changyi Xu; Lijuan Du; Fengjia Chen; Kun Tang; Lu Tang; Jia Shi; Lisha Xiao; Zhimin Zeng; Yuxia Liang; Yubiao Guo
Journal:  BMC Immunol       Date:  2022-05-16       Impact factor: 3.594

4.  Esculetin Attenuates Th2 and Th17 Responses in an Ovalbumin-Induced Asthmatic Mouse Model.

Authors:  Long Hongyan
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

5.  Anti-inflammatory potential of PI3Kδ and JAK inhibitors in asthma patients.

Authors:  Thomas Southworth; Jonathan Plumb; Vandana Gupta; James Pearson; Isabel Ramis; Martin D Lehner; Montserrat Miralpeix; Dave Singh
Journal:  Respir Res       Date:  2016-10-04

6.  IL-2 modulates Th2 cell responses to glucocorticosteroid: A cause of persistent type 2 inflammation?

Authors:  Tharsan Kanagalingam; Lauren Solomon; Meerah Vijeyakumaran; Nami Shrestha Palikhe; Harissios Vliagoftis; Lisa Cameron
Journal:  Immun Inflamm Dis       Date:  2019-04-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.